127 related articles for article (PubMed ID: 15604553)
1. Interleukin-2-associated bullous drug dermatosis.
Hofmann M; Audring H; Sterry W; Trefzer U
Dermatology; 2005; 210(1):74-5. PubMed ID: 15604553
[No Abstract] [Full Text] [Related]
2. Vemurafenib-induced granuloma annulare.
Lee SB; Weide B; Ugurel S; Mössner R; Enk A; Hassel JC
J Dtsch Dermatol Ges; 2016 Mar; 14(3):305-8. PubMed ID: 26972200
[No Abstract] [Full Text] [Related]
3. Meyerson's phenomenon in a patient affected by high-risk melanoma under treatment with interferon-α.
Zonta E; Chiarion V; Zarian H; Peserico A; Alaibac M
Melanoma Res; 2012 Jun; 22(3):284-5. PubMed ID: 22543678
[No Abstract] [Full Text] [Related]
4. Vemurafenib sensitivity skin reaction after ipilimumab.
Harding JJ; Pulitzer M; Chapman PB
N Engl J Med; 2012 Mar; 366(9):866-8. PubMed ID: 22375995
[No Abstract] [Full Text] [Related]
5. A Case of Perforating Folliculitis Induced by Vemurafenib.
Shiraishi K; Masunaga T; Tohyama M; Sayama K
Acta Derm Venereol; 2019 Feb; 99(2):230-231. PubMed ID: 30281138
[No Abstract] [Full Text] [Related]
6. [Persistent inflammatory reaction at the injection site of Il-2 with lymphoma-like inflammatory infiltrates].
Assmann K; Nashan D; Grabbe S; Luger TA; Metze D
Hautarzt; 2002 Aug; 53(8):554-7. PubMed ID: 12221472
[TBL] [Abstract][Full Text] [Related]
7. Neutrophilic panniculitis with vasculitis in a melanoma patient treated with vemurafenib: a case report and its management.
Ueno M; Namiki T; Inui K; Hanafusa T; Miura K; Yokozeki H
Int J Dermatol; 2017 Aug; 56(8):e163-e165. PubMed ID: 28244062
[No Abstract] [Full Text] [Related]
8. Intertriginous and follicular eruption to anticytotoxic T-lymphocyte antigen 4 monoclonal antibody.
Lim JL; Dahiya M; Burgin S
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S60-1. PubMed ID: 18625394
[No Abstract] [Full Text] [Related]
9. Palliation of skeletal melanoma metastases with isolated limb perfusion chemotherapy.
Rajpar SF; Martin-Clavijo A; Marsden JR; Byrne D
Dermatol Surg; 2006 Sep; 32(9):1199-201. PubMed ID: 16970706
[No Abstract] [Full Text] [Related]
10. Dabrafenib-associated necrobiotic granulomatous reaction.
Carlos G; Anforth R; Chou S; Fernandez-Peñas P
Australas J Dermatol; 2014 Nov; 55(4):306-8. PubMed ID: 25399793
[No Abstract] [Full Text] [Related]
11. Inverse Psoriasiform Eruption During Pembrolizumab Therapy for Metastatic Melanoma.
Totonchy MB; Ezaldein HH; Ko CJ; Choi JN
JAMA Dermatol; 2016 May; 152(5):590-2. PubMed ID: 26675815
[No Abstract] [Full Text] [Related]
12. Delayed skin toxicity associated with pembrolizumab therapy for metastatic melanoma.
Arianayagam S; Ieremia E; Matin RN
Eur J Dermatol; 2019 Jun; 29(3):349-351. PubMed ID: 31389799
[No Abstract] [Full Text] [Related]
13. Unstable angina associated with cisplatin and carboplatin in a patient with advanced melanoma.
Khan S; Chen CL; Brady MS; Parameswaran R; Moore R; Hassoun H; Carvajal RD
J Clin Oncol; 2012 Jun; 30(18):e163-4. PubMed ID: 22585705
[No Abstract] [Full Text] [Related]
14. Intra-lesional interleukin-2 for the treatment of in-transit melanoma.
Boyd KU; Wehrli BM; Temple CL
J Surg Oncol; 2011 Dec; 104(7):711-7. PubMed ID: 21744347
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib induces partial response in metastatic medullary thyroid carcinoma.
Spector E; Franklin MJ; Truskinovsky AM; Dudek AZ
Acta Oncol; 2010; 49(1):104-6. PubMed ID: 19711206
[No Abstract] [Full Text] [Related]
16. Unusual complication of vemurafenib treatment of metastatic melanoma: exacerbation of acantholytic dyskeratosis complicated by Kaposi varicelliform eruption.
Gupta M; Huang V; Linette G; Cornelius L
Arch Dermatol; 2012 Aug; 148(8):966-8. PubMed ID: 22911209
[No Abstract] [Full Text] [Related]
17. Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma.
Mochel MC; Ming ME; Imadojemu S; Gangadhar TC; Schuchter LM; Elenitsas R; Payne AS; Chu EY
J Cutan Pathol; 2016 Sep; 43(9):787-91. PubMed ID: 27161449
[TBL] [Abstract][Full Text] [Related]
18. Histopathological aspects of cutaneous erythematous-papular eruptions induced by immune checkpoint inhibitors for the treatment of metastatic melanoma.
Perret RE; Josselin N; Knol AC; Khammari A; Cassecuel J; Peuvrel L; Dreno B;
Int J Dermatol; 2017 May; 56(5):527-533. PubMed ID: 28188628
[TBL] [Abstract][Full Text] [Related]
19. More support for the judicious use of high-dose interleukin-2 in patients with advanced melanoma.
McDermott DF; Atkins MB
J Clin Oncol; 2007 Sep; 25(25):3791-3. PubMed ID: 17761967
[No Abstract] [Full Text] [Related]
20. Occurrence of Psoriasiform Eruption During Nivolumab Therapy for Primary Oral Mucosal Melanoma.
Ohtsuka M; Miura T; Mori T; Ishikawa M; Yamamoto T
JAMA Dermatol; 2015 Jul; 151(7):797-9. PubMed ID: 25875052
[No Abstract] [Full Text] [Related]
[Next] [New Search]
